Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mogensen

Showing results (1-10 of 2,771) with videos related to

Pageof 278
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|July 1, 1995
IMx CA 125, an automated microparticle enzyme immunoassay: technical characteristics and clinical usefulness after recalibrationO Mogensen, B Mogensen
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1992
Measurement of CA 125 by an automated microparticle enzyme immunoassay; comparison with a manual enzyme immunoassayO Mogensen, B Mogensen
Cancer|November 1, 1989
Alpha 1-acid glucoprotein in ovarian cancer with a reference to immunosuppressive acidic protein and cancer antigen 125O Mogensen, B Mogensen, A Jakobsen
Gynecologic Oncology|April 1, 1990
Predictive value of CA 125 during early chemotherapy of advanced ovarian cancerO Mogensen, B Mogensen, A Jakobsen
Gynecologic Oncology|August 1, 1990
Tumor-associated trypsin inhibitor and cancer antigen 125 in pelvic massesO Mogensen, B Mogensen, A Jakobsen
European Journal of Cancer & Clinical Oncology|August 1, 1989
CA 125 in the diagnosis of pelvic massesO Mogensen, B Mogensen, A Jakobsen
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1989
In vitro stability of the immunoreactivity of the ovarian cancer-associated antigen CA 125O Mogensen, B Mogensen, A Jakobsen
British Journal of Cancer|February 1, 1990
Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumoursO Mogensen, B Mogensen, A Jakobsen
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Tissue polypeptide-specific antigen (TPS) as tumour marker in epithelial ovarian cancerJ Blokkebak-Poulsen, O Mogensen, B Mogensen
Acta Obstetricia Et Gynecologica Scandinavica|May 20, 2009
Improvement of women's health--HPV vaccination after 16 years of age?Ole Mogensen
Pageof 278

Showing results (1-10 of 2,771) with videos related to

Sort By:
Pageof 278
Scandinavian Journal of Clinical and Laboratory Investigation|July 1, 1995
IMx CA 125, an automated microparticle enzyme immunoassay: technical characteristics and clinical usefulness after recalibrationO Mogensen, B Mogensen
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1992
Measurement of CA 125 by an automated microparticle enzyme immunoassay; comparison with a manual enzyme immunoassayO Mogensen, B Mogensen
Cancer|November 1, 1989
Alpha 1-acid glucoprotein in ovarian cancer with a reference to immunosuppressive acidic protein and cancer antigen 125O Mogensen, B Mogensen, A Jakobsen
Gynecologic Oncology|April 1, 1990
Predictive value of CA 125 during early chemotherapy of advanced ovarian cancerO Mogensen, B Mogensen, A Jakobsen
Gynecologic Oncology|August 1, 1990
Tumor-associated trypsin inhibitor and cancer antigen 125 in pelvic massesO Mogensen, B Mogensen, A Jakobsen
European Journal of Cancer & Clinical Oncology|August 1, 1989
CA 125 in the diagnosis of pelvic massesO Mogensen, B Mogensen, A Jakobsen
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1989
In vitro stability of the immunoreactivity of the ovarian cancer-associated antigen CA 125O Mogensen, B Mogensen, A Jakobsen
British Journal of Cancer|February 1, 1990
Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumoursO Mogensen, B Mogensen, A Jakobsen
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Tissue polypeptide-specific antigen (TPS) as tumour marker in epithelial ovarian cancerJ Blokkebak-Poulsen, O Mogensen, B Mogensen
Acta Obstetricia Et Gynecologica Scandinavica|May 20, 2009
Improvement of women's health--HPV vaccination after 16 years of age?Ole Mogensen
Pageof 278